- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02705287
Vitamin D Dynamics in Women
Vitamin D Dynamics in Pregnant Women and Non-Pregnant Women of Reproductive Age
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Nearly 30% of US women are either vitamin D insufficient or deficient. Vitamin D inadequacy during gestation is increasingly linked to adverse birth outcomes including preterm birth, the risk of cesarean section and placental and pregnancy-associated infections. At this time the Institute of Medicine (IOM) has not advocated any increase in vitamin D intake across gestation but this remains controversial in large part due to insufficient information on the basic physiology of vitamin D. Pregnancy induces dramatic changes in regulation of vitamin D. The investigators hypothesize that increased maternal, placental, and fetal vitamin D requirements during late gestation will result in an increase in vitamin D absorption and a decrease in the half-life of both vitamin D3 and 25-hydroxyvitamin D. The fetus is entirely dependent on maternal vitamin D to meet its requirements for this nutrient. Maternal vitamin D is thought to be passively transferred across the placenta to the fetus given that neonatal concentrations of 25(OH)D are at least 20-30% lower than maternal 25(OH)D concentrations. To date, much of what is known about vitamin D absorption and utilization in humans has been extrapolated from early radiotracer studies in adult men and non-pregnant women and there are no in vivo data to determine if maternal vitamin D3 or maternal 25(OH)D3, or both, can be transferred across the placenta to the fetus
The specific aims of this project are to:
- To characterize the impact of pregnancy on the absorption of vitamin D3, conversion into 25(OH)D3, and serum half-life of 25OH)D3 in pregnant and non-pregnant women using tri-deuterated vitamin D3, state of the art UHPLC-MS/MS methodology and mathematical modeling.
- To study the impact of obesity on vitamin D kinetics and the D content of serum and adipose tissue in pregnant and non-pregnant women.
- To evaluate the impact of genetic ancestry on vitamin D kinetics and the D content of serum and adipose tissue in pregnant and non-pregnant women.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
New York
-
Rochester, New York, United States, 14627
- University of Rochester, 518 Hylan Building
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria (Non-pregnant and pregnant participants participants):
- Self-reported White and Black women
- Age 20-39
- Body mass index (BMI) 1or pre-pregnancy BMI (If currently pregnant) either 18.5-24.9 kg/m2 or greater than or equal to 30 kg/m2
Inclusion Criteria (Additional criteria for pregnant participants):
- Singleton pregnancy
- Recruited in first trimester, second trimester, or third trimester
- No pregnancy complications
Exclusion Criteria (Non-pregnant and pregnant participants):
- BMI or pre-pregnancy BMI <18.5 kg/m2
- Human immunodeficiency virus (HIV) infection
- Diagnosed eating disorder
- Malabsorption disease
- Diabetes
- Elevated diastolic blood pressure (>110 mm/Hg)
- Steroid use
- Substance abuse history
- Current use of medications known to influence vitamin D or calcium homeostasis
- Plans to travel to lower latitude during the 20-day study period
- Plans to become pregnant during the study period (non-pregnant only)
- Refuses to discontinue tanning bed use during study period
- Refuses to discontinue vitamin or mineral supplement use during study period (non-pregnant only)
Exclusion Criteria (Additional criteria for pregnant participants):
- Gestational diabetes
- Pregnancy hypertension
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Vitamin D dynamics-pregnant
Pregnant women recruited to measure Vitamin D dynamics during pregnancy.
|
tracer dose of deuterated vitamin D3
|
Vitamin D dynamics-nonpregnant
Non-pregnant women recruited to measure Vitamin D dynamics.
|
tracer dose of deuterated vitamin D3
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum vitamin D3 half-life
Time Frame: Across 30 days study period
|
A baseline blood sample (20 mL) will be obtained for analysis of the baseline concentrations of calcitropic hormones and indicators of vitamin D status.
Each woman will be asked to ingest one quarter piece of toast onto which a dose of 25 μg (1000 IU) of [6,19,19-d3]-vitamin D3 has been added.
Women will return to the on Day 2, 8, 12, 16, 20 and 30 (± 2 days) for an additional blood sample (10 mL each) to assess the disappearance of the deuterated D3.
|
Across 30 days study period
|
Forms of vitamin D can be transferred across the placenta
Time Frame: Across 1-2 days study period
|
At delivery a sample of cord blood and placental tissue will be obtained to evaluate the presence of labeled vitamin D or its metabolites in the neonate at birth and in the placental tissue
|
Across 1-2 days study period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum 25-hydroxyvitamin D3 half-life
Time Frame: Across 30 days study period
|
A baseline blood sample (20 mL) will be obtained for analysis of the baseline concentrations of calcitropic hormones and indicators of vitamin D status.
Each woman will be asked to ingest one quarter piece of toast onto which a dose of 25 μg (1000 IU) of [6,19,19-d3]-vitamin D3 has been added.
Women will return to the on Day 2, 8, 12, 16, 20 and 30 (± 2 days) for an additional blood sample (10 mL each) to examine the appearance and subsequent disappearance of deuterated 25(OH)D3.
|
Across 30 days study period
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB # 1509005821
- RSRB00057617 (Other Identifier: University of Rochester)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Turku University HospitalUniversity of TurkuCompleted
-
Hopital Antoine BeclereUnknown
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
Clinical Trials on Vitamin D dynamics-pregnant
-
Universidad de GranadaRecruitingCovid19 | Pregnancy ComplicationsSpain
-
PfizerTerminated
-
Umeå UniversityRegion SkaneCompleted
-
Khon Kaen UniversityNot yet recruiting
-
Fundación Cardiovascular de ColombiaUniversidad Industrial de Santander; Farma de Colombia SACompletedVitamin D Deficiency | Overweight and Obesity | Overweight AdolescentsColombia
-
Nutrition Institute, SloveniaSlovenian Research Agency; Higher School of Applied Sciences (VIST); Valens Int...CompletedVitamin D DeficiencySlovenia
-
USDA, Western Human Nutrition Research CenterCompletedVitamin D DeficiencyUnited States
-
University of AarhusNot yet recruitingImmune System Diseases | Growth | Child Development | Vitamin D Supplementation
-
University Hospital, Basel, SwitzerlandCompleted
-
Cornell UniversityArogyavaram Medical CentreNot yet recruiting